Legend Biotech (LEGN) is a publicly traded Healthcare sector company. As of September 6, 2026, LEGN trades at $21.55 with a market cap of $4.19B and a P/E ratio of 0.00. LEGN moved -1.10% today. Year to date, LEGN is +0.05%; over the trailing twelve months it is -40.35%. Its 52-week range spans $16.24 to $45.30. Analyst consensus is buy with an average price target of $48.07. Rallies surfaces LEGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for LEGN shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $21.55 |
| Market Cap | $4.19B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $45.30 |
| 52-Week Low | $16.24 |
| Volume | 659.66K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
10 analysts cover LEGN: 0 strong buy, 6 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $48.07.